Follow Us
https://www.thebody.com/author/coverage-provided-ramon-torres

Latest by Ramon Torres, M.D.

Promo Image

AZT Resistance Predicts Poor Outcome

Several studies presented at the 4th National Conference on Retroviruses and Opportunistic Infections evaluated the effect of AZT resistance codon mutations on outcome. One of the most important studies presented by David Katzenstein and other member...

Promo Image
News

Final Results of CAESAR Study Demonstrate a Survival Benefit with 3TC

Dr.David Cooper from St. Vincent's Hospital in Sydney, Australia presented the final results of the multicenter study called CAESAR (conducted in Canada, Australia, Europe and South Africa) at the 4th National Conference on Retroviruses and Opportuni...

Promo Image
News

ddI + d4T Combination Therapy Proves Effective

Two French studies presented at the 4th National Conference on Retroviruses and Opportunistic infections confirmed the benefit of combination therapy with ddI and d4T. One group from Nice led by Durant treated 25 patients with mean entry CD4 counts o...

Promo Image
News

Can HIV be Eradicated?

David Ho, M.D., the leading HIV researcher in the United States, who was recently recognized by TIME magazine as Man of the Year for his contribution to the understanding of the pathogenesis of HIV infection, stated at the opening session of the 4th ...

Promo Image

Antiretroviral Drug Interaction Studies Show Favorable Effects

Various antiretroviral drug-drug interaction studies presented at the National Conference on Retroviruses and Opportunistic Infections showed favorable effects which may be beneficial in clinical practice. These pharmacokinetic studies combined eithe...

Promo Image
News

Expanding Information on Nelfinavir, the Next Protease Inhibitor

Nelfinavir is a potent protease inhibitor developed by Agouron Pharmaceuticals. It has been submitted to the FDA for accelerated approval and will be marketed under the brand name "Viracept. " Presentations at the 4th Retrovirus conference summarized...

Promo Image
News

Protease Combinations May Be the Most Effective

John Mellors from the University of Pittsburgh gave one of the most compelling oral presentations at the 4th National Conference on Human Retroviruses and Opportunistic Infections in Washington, D.C. when he addressed the issue of combining two prote...

Promo Image
News

Ritonavir-Saquinavir Combination Therapy in Patients with Advanced HIV Infection

Two small studies presented at the National Conference on Retroviruses and Opportunistic Infections in Washington,D.C. examined the effect of the combination of ritonavir and saquinavir in advanced HIV positive patients. Prior to these studies, the c...